CHC Healthcare Group (4164.TW)
- Previous Close
44.10 - Open
43.80 - Bid 42.40 x --
- Ask 42.50 x --
- Day's Range
42.20 - 44.00 - 52 Week Range
35.50 - 60.40 - Volume
1,555,080 - Avg. Volume
2,442,933 - Market Cap (intraday)
7.058B - Beta (5Y Monthly) 0.37
- PE Ratio (TTM)
41.47 - EPS (TTM)
1.02 - Earnings Date Aug 5, 2025 - Aug 11, 2025
- Forward Dividend & Yield 2.00 (4.55%)
- Ex-Dividend Date Jul 10, 2024
- 1y Target Est
55.00
CHC Healthcare Group, together with its subsidiaries, engages in trading of pharmaceutical products and health food in Taiwan, China, and internationally. The company is also involved in the sale, leasing, installing, and repairing of medical instruments. In addition, it engages in the sale of ophthalmic equipment; irradiation business; sale of drug and health supplements; consulting, elderly residence, and senior fitness services; Long-term care services; and leasing of veterinary medical instruments. CHC Healthcare Group was founded in 1977 and is headquartered in Taipei City, Taiwan.
www.chcg.comRecent News: 4164.TW
View MorePerformance Overview: 4164.TW
Trailing total returns as of 5/22/2025, which may include dividends or other distributions. Benchmark is TSEC CAPITALIZATION WEIGHTED ST (^TWII) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 4164.TW
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 4164.TW
View MoreValuation Measures
Market Cap
7.36B
Enterprise Value
10.83B
Trailing P/E
43.24
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.86
Price/Book (mrq)
1.07
Enterprise Value/Revenue
2.74
Enterprise Value/EBITDA
11.09
Financial Highlights
Profitability and Income Statement
Profit Margin
4.42%
Return on Assets (ttm)
1.18%
Return on Equity (ttm)
2.69%
Revenue (ttm)
3.95B
Net Income Avi to Common (ttm)
174.52M
Diluted EPS (ttm)
1.02
Balance Sheet and Cash Flow
Total Cash (mrq)
1.77B
Total Debt/Equity (mrq)
72.25%
Levered Free Cash Flow (ttm)
-553.08M